Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sterling Products Corporation, later known as Sterling Drug, was a major American pharmaceutical company that played a pivotal role in the 20th-century drug industry. The company is most famous for its 1918 acquisition of the U.S. assets of Bayer, which granted it the rights to the Bayer Aspirin brand in the United States. Throughout its history, Sterling developed and marketed a wide array of successful products, including Phillips' Milk of Magnesia, Midol, and the analgesic Demerol. In 1988, the company was acquired by Eastman Kodak for $5.1 billion in a strategic move to diversify into the life sciences sector. However, Kodak eventually divested the business, selling the pharmaceutical division to Sanofi and the consumer health unit to SmithKline Beecham.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sterling Products.